Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric B Haura

Showing results (21-30 of 213) with videos related to

Pageof 22
Sort By:
Pharmacological Research|December 6, 2017
CAR-T cells and combination therapies: What's next in the immunotherapy revolution?Maria C Ramello, Eric B Haura, Daniel Abate-Daga
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Erdafitinib Overcomes FGFR3-TACC3-Mediated Resistance to OsimertinibEric B Haura, J Kevin Hicks, Theresa A Boyle
Chest|July 9, 2005
Small tumor size and limited smoking history predicts activated epidermal growth factor receptor in early-stage non-small cell lung cancerZhong Zheng, Gerold Bepler, Alan Cantor, et al.
Molecular Cancer Therapeutics|January 11, 2011
JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signalingLanxi Song, Bhupendra Rawal, Jeffrey A Nemeth, et al.
Cancer Immunology Research|June 18, 2015
Charting Immune Signaling Proteomes En Route to New Therapeutic StrategiesEric B Haura, Amer A Beg, Uwe Rix, et al.
Journal of Pharmacy Practice|May 3, 2012
Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literatureAli McBride, Scott J Antonia, Eric B Haura, et al.
Cancer Biology & Therapy|March 9, 2005
Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cellsLanxi Song, Domenico Coppola, Sandy Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancerEric B Haura, Zhong Zheng, Lanxi Song, et al.
Molecular Cancer Therapeutics|September 19, 2007
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cellsArthur Edwards, Jiannong Li, Peter Atadja, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 14, 2007
Effects of IFN-gamma and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cellsJiannong Li, Bin Yu, Lanxi Song, et al.
Pageof 22

Showing results (21-30 of 213) with videos related to

Sort By:
Pageof 22
Pharmacological Research|December 6, 2017
CAR-T cells and combination therapies: What's next in the immunotherapy revolution?Maria C Ramello, Eric B Haura, Daniel Abate-Daga
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Erdafitinib Overcomes FGFR3-TACC3-Mediated Resistance to OsimertinibEric B Haura, J Kevin Hicks, Theresa A Boyle
Chest|July 9, 2005
Small tumor size and limited smoking history predicts activated epidermal growth factor receptor in early-stage non-small cell lung cancerZhong Zheng, Gerold Bepler, Alan Cantor, et al.
Molecular Cancer Therapeutics|January 11, 2011
JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signalingLanxi Song, Bhupendra Rawal, Jeffrey A Nemeth, et al.
Cancer Immunology Research|June 18, 2015
Charting Immune Signaling Proteomes En Route to New Therapeutic StrategiesEric B Haura, Amer A Beg, Uwe Rix, et al.
Journal of Pharmacy Practice|May 3, 2012
Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literatureAli McBride, Scott J Antonia, Eric B Haura, et al.
Cancer Biology & Therapy|March 9, 2005
Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cellsLanxi Song, Domenico Coppola, Sandy Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancerEric B Haura, Zhong Zheng, Lanxi Song, et al.
Molecular Cancer Therapeutics|September 19, 2007
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cellsArthur Edwards, Jiannong Li, Peter Atadja, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 14, 2007
Effects of IFN-gamma and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cellsJiannong Li, Bin Yu, Lanxi Song, et al.
Pageof 22